Adam Stępień

3.3k total citations · 1 hit paper
147 papers, 1.7k citations indexed

About

Adam Stępień is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Adam Stępień has authored 147 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 29 papers in Pathology and Forensic Medicine and 27 papers in Epidemiology. Recurrent topics in Adam Stępień's work include Arctic and Russian Policy Studies (20 papers), Acute Ischemic Stroke Management (20 papers) and Multiple Sclerosis Research Studies (17 papers). Adam Stępień is often cited by papers focused on Arctic and Russian Policy Studies (20 papers), Acute Ischemic Stroke Management (20 papers) and Multiple Sclerosis Research Studies (17 papers). Adam Stępień collaborates with scholars based in Poland, United States and Canada. Adam Stępień's co-authors include Jerzy Michalak, A Kadziołka, Jacek Staszewski, Małgorzata Chalimoniuk, Bogdan Brodacki, Beata Toczyłowska, Nadzieja Drela, Ewa Kozłowska, Henryk Jęśko and Robert P. Strosznajder and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Adam Stępień

127 papers receiving 1.7k citations

Hit Papers

The relationship between plasma triglycerides, cholestero... 1986 2026 1999 2012 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Stępień Poland 19 374 322 297 288 286 147 1.7k
San‐Nan Yang Taiwan 34 237 0.6× 700 2.2× 286 1.0× 419 1.5× 220 0.8× 123 2.8k
Ralf A. Linker Germany 24 346 0.9× 636 2.0× 360 1.2× 287 1.0× 168 0.6× 71 2.4k
Arumugam R. Jayakumar United States 24 225 0.6× 410 1.3× 193 0.6× 217 0.8× 376 1.3× 61 1.6k
Shujuan Li China 23 158 0.4× 552 1.7× 252 0.8× 218 0.8× 526 1.8× 110 1.9k
Binu Tharakan United States 25 358 1.0× 919 2.9× 331 1.1× 302 1.0× 253 0.9× 88 2.3k
Monica Molteni Italy 21 151 0.4× 561 1.7× 457 1.5× 278 1.0× 116 0.4× 37 2.3k
Chiara Ippolito Italy 26 171 0.5× 421 1.3× 110 0.4× 340 1.2× 205 0.7× 71 1.6k
Vadim S. Ten United States 29 190 0.5× 786 2.4× 257 0.9× 233 0.8× 184 0.6× 60 2.1k
Yumin Liu China 22 251 0.7× 744 2.3× 127 0.4× 282 1.0× 188 0.7× 108 1.9k

Countries citing papers authored by Adam Stępień

Since Specialization
Citations

This map shows the geographic impact of Adam Stępień's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Stępień with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Stępień more than expected).

Fields of papers citing papers by Adam Stępień

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Stępień. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Stępień. The network helps show where Adam Stępień may publish in the future.

Co-authorship network of co-authors of Adam Stępień

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Stępień. A scholar is included among the top collaborators of Adam Stępień based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Stępień. Adam Stępień is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Synowiec, Agnieszka, et al.. (2025). The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases. Frontiers in Molecular Neuroscience. 17. 1493308–1493308. 1 indexed citations
2.
Dziedzic, Angela, et al.. (2023). Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review. Frontiers in Molecular Neuroscience. 16. 1210091–1210091. 8 indexed citations
5.
Truszczyńska-Baszak, Aleksandra, et al.. (2022). Functional Therapeutic Strategies Used in Different Stages of Alzheimer’s Disease—A Systematic Review. International Journal of Environmental Research and Public Health. 19(18). 11769–11769. 3 indexed citations
6.
Piasecki, Piotr, et al.. (2021). Inadvertent Detachment of Stent Retrievers during Mechanical Thrombectomy—A Clinical and Biomechanical Perspective. Life. 11(7). 658–658. 1 indexed citations
7.
Stępień, Adam, et al.. (2020). Paroxysmal extreme pain disorder in family with c.3892G > T (p.Val1298Phe) in the SCN9A gene mutation – case report. BMC Neurology. 20(1). 182–182. 5 indexed citations
8.
Staszewski, Jacek, et al.. (2018). Aspirin Resistance: Risk Factors and Prognostic Significance in Patients with Cerebral Small Vessel Disease.. PubMed. 48(1). 45–54. 4 indexed citations
9.
Potemkowski, Andrzej, Waldemar Brola, Katarzyna Kapica-Topczewska, et al.. (2017). The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others. Neuropsychiatric Disease and Treatment. Volume 13. 1817–1824. 5 indexed citations
10.
Stępień, Karolina M., et al.. (2016). Adipose‐Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?. Stem Cells International. 2016(1). 5762916–5762916. 24 indexed citations
11.
Stępień, Adam, et al.. (2016). Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results. Mediators of Inflammation. 2016. 1–5. 35 indexed citations
12.
Stępień, Adam, et al.. (2016). [Mitoxantrone role in treatment of primary progressive multiple sclerosis].. PubMed. 40(235). 66–9. 4 indexed citations
13.
Sarkki, Simo, et al.. (2014). Socio-Natural Capital for Sustainable Land Use in the Fennoscandia. Jukuri (Natural Resources Institute Finland (Luke)). 307–323. 1 indexed citations
14.
Koivurova, Timo, et al.. (2013). Addressing climate vulnerability : promoting the participatory rights of indigenous peoples and women through Finnish foreign policy. SSRN Electronic Journal. 185. 105172–105172. 1 indexed citations
15.
Stępień, Adam, et al.. (2013). Lithology of soils in the Supraśl River valley (E Poland) and their ability to hold pollution. Geological Quarterly. 37(3). 467–484. 2 indexed citations
17.
Koivurova, Timo & Adam Stępień. (2011). How international law has influenced the national policy and law related to indigenous peoples in the Arctic. LaCRIS (University of Lapland). 19(1). 123. 1 indexed citations
18.
McGlynn, Emily, Martin Brückner, Christine Polzin, et al.. (2010). EU arctic footprint and policy assessment:final report. LaCRIS (University of Lapland). 4 indexed citations
19.
Stępień, Adam, et al.. (2010). Nowe wytyczne dotyczące leczenia bólu neuropatycznego. Neurologia i Neurochirurgia Polska. 44(5). 437–442. 3 indexed citations
20.
Stępień, Adam & Wojciech Kozubski. (2004). [Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks].. PubMed. 57(3-4). 135–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026